logo
  

Hochschild Says Prepared To Enter Into Dialogue With Peru On Mining Issue

Hochschild Mining PLC (HOC.L, HCHDF) said the Peruvian Head of Cabinet indicated that approvals will no longer be granted to facilitate additional mining or exploration activities regarding the company's Pallancata and Inmaculada mining operations.

The company said it has not received any formal communication from the government regarding the matter.

The company said it has learnt through various media outlets of minutes of a meeting signed by the Peruvian Head of Cabinet, certain vice-ministers as well as regional authorities in the town of Coracora in the Ayacucho region. The minutes refer to alleged environmental complaints, and state that a commission has been constituted in order to negotiate the timetable and terms for the closure of certain mining projects in southern Ayacucho, including the company's Pallancata and Inmaculada mines.

The company said it is prepared to enter into a dialogue with the government in order to resolve any misunderstandings with respect to its mining operations. The company will vigorously defend its rights to operate the mines using all available legal avenues.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
This Black Friday and the following holiday season, retailers across the United States are urged to keep up their inventory amid expected surge in shopping as majority of Americans wait till last minute to fill their baskets, according to certain studies. A new Oracle Retail survey, which was conducted last week and presented earlier this week, showed that 66 percent of consumers were less than Eagle, Idaho -based Flagship Food Group is recalling certain TJ Farms Select brand frozen cauliflower, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves a limited number of cases of TJ Farms Select cauliflower that comes in 16 oz. packages with lot code 2077890089 and UPC code 75544000604-3. The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Co. Ltd.'s Livtencity (maribavir) as the first drug to treat post-transplant cytomegalovirus or CMV in adults and pediatric patients. The approval is to treat patients 12 years of age and older and weighing at least 35 kilograms with post-transplant CMV infection/disease that does not respond...
Follow RTT